fingolimod hydrochloride has been researched along with Keratitis, Herpetic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khatri, M; Rajasagi, NK; Reddy, PB; Rouse, BT; Sehrawat, S; Suryawanshi, A | 1 |
| Rouse, BT; Sehrawat, S | 1 |
2 other study(ies) available for fingolimod hydrochloride and Keratitis, Herpetic
| Article | Year |
|---|---|
An approach to control relapse of inflammatory lesions after discontinuation of primary therapy.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Cell Differentiation; Disease Models, Animal; Female; Fingolimod Hydrochloride; Herpesvirus 1, Human; Immunosuppressive Agents; Interleukin-6; Keratitis, Herpetic; Mice; Mice, Knockout; Propylene Glycols; Receptors, Lysosphingolipid; Recurrence; Secondary Prevention; Sphingosine; T-Lymphocyte Subsets | 2014 |
Anti-inflammatory effects of FTY720 against viral-induced immunopathology: role of drug-induced conversion of T cells to become Foxp3+ regulators.
Topics: Animals; CD4-Positive T-Lymphocytes; Female; Fingolimod Hydrochloride; Forkhead Transcription Factors; Herpesvirus 1, Human; Immunosuppressive Agents; Keratitis, Herpetic; Lymphocyte Count; Mice; Mice, Mutant Strains; Propylene Glycols; Sphingosine; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Transforming Growth Factor beta | 2008 |